Table 4.
FHR studies examining neuroimaging markers.
Study (ref) |
Cohort | Population | Model variables of interest | Outcome of interest | Results Reported | ||||
---|---|---|---|---|---|---|---|---|---|
Sensitivity | Specificity | PPV | NPV | ||||||
43 | EHRS | A –65 HR subjects B –18 HR subjects with transient or partial psychotic symptoms |
Grey matter changes in R cerebellum, L uncus, L inferior temporal gyrus |
HR subjects developing schizophrenia versus those remaining well |
A | 0.13– 0.38 |
0.88–0.96 | 0.20– 0.60 |
0.88– 0.92 |
B | 0.38– 0.63 |
0.70–0.80 | 0.50– 0.71 |
0.58– 0.73 |
|||||
44 | EHRS | 21 control subjects, 41 HR without psychotic symptoms, 21 HR with psychotic symptoms (4 HR subsequently ill) |
fMRI parietal lobe activation, anterior cingulate deactivation, reduced right lingual gyrus and temporal activation |
HR subjects developing schizophrenia versus those remaining well |
ROIs | - | - | 0.17– 0.80 |
0.98– 1.00 |
DFA | - | - | 0.50– 0.60 |
0.95– 0.98 |
Cohorts: EHRS, Edinburgh High Risk Study. ROIs, regions of interest. DFA, discriminant function analysis. Model variables of interest include variables that were ultimately nonsignificant; readers are encouraged to refer to the text or the original article for additional information.